2-(2-Fluoro-4-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g

8-methyl-4-[4-(trifluoromethyl)benzoyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

2-(3,4-Difluorophenyl)oxirane, 95.0%, 500mg

(2,6-dimethoxy-4-methylphenyl)boronic acid, 95.0%, 250mg

7-methyl-5-(1-methyl-2-oxopropoxy)-4-propyl-2H-chromen-2-one, 95.0%, 5g

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID, 95.0%, 1g

Ethyl 3-(4-Cyanophenyl)-3-oxopropionate>98.0%(GC)(T)200mg

4,7-dibromo-6-fluoro-2,3-dihydro-1H-indol-2-one, 95.0%, 250mg

tert-Butyl 3-amino-1H-1,2,4-triazole-1-carboxylate, 95%, 100mg

3,6-Difluoro-9H-carbazole, 98%, 100mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzene-1,2-diamine, 97%, 100mg

Flacon à col étroit ROTILABO® avec homologation UN Volume, 1000ml, carré, 6 Pièce(s)

Hexcyanoferrate(III) de potassium, min 99 %, technique, 500 g, emballage plastique.